StockClub
NURPFNeuren Pharmaceuticals Limited$ --
Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Limited

NURPF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
36M AUD
YoY -81.1%
Operating Income
11M AUD
YoY -93.0%
Net Income
15M AUD
YoY -88.5%
EPS
0.12AUD
YoY -88.3%

Revenue

AUD64.6M
FY2022 Q2AUD0
AUD0
Q2
FY2022 Q4AUD14.6M
AUD14.6M
Q4
FY2023 Q2AUD62.9M
AUD62.9M
Q2
FY2023 Q4AUD231.9M
AUD231.9M
Q4
FY2024 Q2AUD24.3M
AUD24.3M
Q2
FY2024 Q4AUD216.8M
AUD216.8M
Q4
FY2025 Q2AUD28.3M
AUD28.3M
Q2
FY2025 Q4AUD64.6M
AUD64.6M
Q4
Actual
AUD-152.2M (-70.2%)

Net Income

AUD30.4M
FY2022 Q2AUD-7.1M
AUD-7.1M
Q2
FY2022 Q4AUD184,000
AUD184,000
Q4
FY2023 Q2AUD47.8M
AUD47.8M
Q2
FY2023 Q4AUD157.1M
AUD157.1M
Q4
FY2024 Q2AUD8M
AUD8M
Q2
FY2024 Q4AUD142M
AUD142M
Q4
FY2025 Q2AUD15M
AUD15M
Q2
FY2025 Q4AUD30.4M
AUD30.4M
Q4
Actual
AUD-111.6M (-78.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:AUD717,000
Est:AUD14.6M
FY2020MISS
AUD717,000
FY2021BEAT
Actual:AUD3.2M
Est:AUD1.9M
FY2021BEAT
AUD3.2M
FY2022MISS
Actual:AUD14.6M
Est:AUD15.4M
FY2022MISS
AUD14.6M
FY2023MISS
Actual:AUD231.9M
Est:AUD233.4M
FY2023MISS
AUD231.9M
FY2024BEAT
Actual:AUD216.8M
Est:AUD213.1M
FY2024BEAT
AUD216.8M
FY2025MISS
Actual:AUD64.6M
Est:AUD67.6M
FY2025MISS
AUD64.6M

Analyst Estimates